Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

641 public trials 135 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

NCT07347600

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Gansu Provincial Maternal and Child Health Hospital (Gansu Provincial Hospital of Traditional Chinese Medicine) Lanzhou, Gansu, China
  • The First Hospital of Jilin University Changchun, Jilin, China
  • Wenzhou Medical University Affiliated Second Hospital Wenzhou, Zhejiang, China
View all 30 locations
View Trial Details
Recruiting

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

NCT06377852

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Ironwood Cancer & Research Centers Gilbert, Arizona, United States
  • Ironwood Cancer & Research Centers Glendale, Arizona, United States
  • Ironwood Cancer & Research Centers Goodyear, Arizona, United States
View all 73 locations
View Trial Details
Recruiting

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

NCT06982521

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +9 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 231 locations
View Trial Details
Recruiting

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

NCT05846789

Conditions
Breast Diseases, Breast Neoplasms, ER Positive, HER2 Negative Breast Cancer, +8 more
Locations
  • Emory University Atlanta, Georgia, United States
  • IU Health Joe and Shelly Schwarz Cancer Center Carmel, Indiana, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
View Trial Details
Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT05868226

Conditions
Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details
Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

NCT06072612

Conditions
Breast Cancer, Breast Cancer Metastatic, Breast Diseases, +12 more
Locations
  • Mayo Clinic-Comprehensive Cancer Center-Breast Clinic Phoenix, Arizona, United States
  • University of Arizona-Cancer Center Tucson, Arizona, United States
  • Los Angeles cancer Network_Anaheim Anaheim, California, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
View all 79 locations
View Trial Details
Recruiting

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

NCT05964504

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions